A number of translation inhibitors were tested for their effects on both control and encephalomyocarditis virus-infected mouse 3T6 cells. The virus-infected cells were specifically inhibited by gougerotin, edeine, and blasticidin S, whereas these drugs failed to penetrate into uninfected cells. Inhibition of infected cells by gougerotin became apparent when the synthesis of viral proteins commenced, suggesting that the latter process is accompanied by a permeability change in the cells that allows uptake of the drug. This permeability change was not observed in cells treated with cycloheximide soon after viral infection, although treatment with actinomycin D did not prevent inhibition by gougerotin. It is possible, therefore, that a specific viral protein is involved in the permeability change of the plasma membrane. Moreover, gougerotin was unable to inhibit protein synthesis in the presence of zinc ions, thus preventing gougerotin from entering into the infected cell. Membrane leakiness was not restricted to the encephalomyocarditis virus-3T6 system; it was also observed in mengovirus-infected 3T6 cells, Semliki Forest virus-infected BHK cells, and simian virus 40-infected CV1 cells at the time in which the synthesis of late proteins is maximal.
Normal cell metabolism is disrupted upon viral infection. Recently we proposed that this was caused by an alteration in membrane function resulting from viral proteins becoming integrated into the plasma membrane and altering its permeability properties (3, 5) . Experiments which support this suggestion have shown that infection of mouse cells with encephalomyocarditis (EMC) virus makes the membranes leaky to monovalent ions, allowing entry of sodium into the cytoplasm with a release of potassium ions into the surrounding medium (9) . Such changes in concentrations of ions in the cytoplasm might be responsible for many of the metabolic alterations observed after viral infection of susceptible cells (1, 3, 18) . Furthermore, the in vitro synthesis of viral proteins requires ion concentrations different from those found to be optimal for efficient translation of cellular mRNA's (5) .
Changes in the permeability of plasma membranes after viral infection allow not only ionic changes in the cytoplasm but also the redistri- Spain. bution of other small metabolites (6, 17) , and induction of membrane leakiness could be a general property shared by many viruses that infect either eucaryotic or procaryotic organisms (3, 6, 17) . Using GppCH2p, a nucleotide analog that inhibits protein synthesis in cell-free systems, we observed that the membrane of an infected cell became permeable at the onset of viral protein synthesis. Inhibition by GppCH2p was specific for infected cells (4), favoring the interpretation that such cells become permeable to GppCH2p and thus allow entry of this compound into the cytoplasm, where protein synthesis is then inhibited.
It remained to be demonstrated whether permeability of infected cells was specific only to GppCH2p or whether any small compound, irrespective of its structural formula, could permeate cells infected by viruses known to induce the cytopathic effect (18) . Furthermore, it was of interest to screen certain antibiotics known to preferentially affect protein synthesis in cell-free systems, to determine if these were also specific inhibitors of virus-infected cells. The experiments reported here were designed to answer these questions and to ascertain whether any relationship exists between the particular stage of viral development and the induction of membrane permeability in infected cells. 3T6 cells were grown in 30-mm petri dishes containing 2 ml of ElDo. When the cell monolayer was confluent, the medium was removed, and samples were mockinfected or infected with EMC virus (1 to 2 PFU/cell). After incubation for 1 h at 37°C, the medium was removed, 1 ml of E,D medium containing 5% calf serum (E4D5) was added, and the dishes were incubated for a further 4 h at 370C. The medium was then replaced by 0.5 ml of EJD medium without methionine and supplemented with 1% calf serum (E4lD-Met).
The indicated concentration of inhibitor was then added, and incubation was imediately continued for 30 min at 370C. After this time, 2 i1 of [TMS]methionine (885 Ci/mmoL 2 mCi/ml) was added, and the dishes were further incubated for 1 h at 370C.
(ii) MengovirusM cell system. Experimental conditions were as described above except that the multiplicity of infection was 5 PFU/cell. The dishes were incubated for 5 h at 37°C before ElD5 medium was replaced by E4Ds-Met medium and then incubated for 1 h at 370C after the addition ofthe inhibitors and before the addition of ['S]methionine.
(iii) SFV-BHEK cell system. BHK cells were grown and subsequently mock-infected or infected (50 PFU/cell) by SFV as descibed above, except that after virus absorption the medium was removed and replaced by 2 ml of E4D medium containing 2 mg of bovine serum albumin per ml. The dishes were then incubated for 5 h at 370C. Proteins were labeled by first incubating the cells in the presence of the inhibitor for 2 h and then labeling with 3 i1 of [mS]methionine (886 Ci/mmol, 2 mCi/ml) for another hour.
(iv) SV40-CV1 cell system. CV1 cells were grown in 30-mm petri dishes containg 2 ml of E4Do. Subconfluent cell monolayers were mock-infected or infected with SV40 (70 PFU/cell). After absorption for 2 h at 370C (0 time in the infection process), the medium was removed, 2 ml of E4D medium containing 5% fetal calf serum was added, and the dishes were incubated at 370C. Protein synthesis was measured by labeling the proteins with ['3S]methionine at 17 to 18 and 41 to 42 h postinfection. For this purpose, the medium was removed and replaced by 0.5 ml of El)DMet medium conaning the inhibitor at the indicated concentration. The dishes were incubated for 1.5 h at 370C. After this time, 4 pl of [TMSlmethionine (885 Ci/ mmol, 2 mCi/ml) was added, and the incubation was continued for 1 h at 370C.
Polyacrylamide gel electrophoresis. After the cells were incubated for 1 h at 370C in the presence of
[36S]methionine (systems i, ii, iii, and iv above), the medium was removed, and the cell monolayer was washed with 2 ml of phosphate buffer. The cells were diolved in 0.15 ml of 0.1 N NaOH containing 0.1% sodium dodecyl sulfate and 0.15 ml of sample buffer. Each sample was sonically disrupted to reduce the viscosity and heated to 90°C for 10 min. Samples of 10 p1 were analyzed by polyacrylamide gel electrophoresis using 15% acrylamide gels. The gels were run overnight at 25 V. When the bromophenol blue tracker dye reached the bottom of the gels, electrophoresis was stopped and the gels were stained and destained. Fluorography with dimethyl sulfoxide-2,5-diphenyloxazole (20%, wt/wt) was then carried out, and the gels were dried. The gels were finally subjected to autoradiography (Kodak XH1 film), and the developed film was analyzed on a densitometer.
Measurement of protein synthesis. (i) EMC virus-M cell system. 3T6 cells were grown and subsequently mock-infected or infected (1 to 2 PFU/cell) as descibed above. At 4 h after medium addition, the indicated amount of inhibitor was added directly to the medium, and the incubation was continued for 30 min. [3,4-3H]proline (10 ,ud per dish; 41 Ci/mmol, 0.2 mCi/ml) was added, and after 1 h of incubation at 37°C the medium was removed. The cell monolayer was washed with 3 ml of saline phosphate buffer and 1 ml of 5% trichloroacetic acid. The precipitated cell monolayer was thoroughly washed three times with ethanoL The cell monolayer was dried under an infrared lamp, 0.5 ml of 0.1 N NaOH was added, and the mixture was kept for 15 min at room temperature. Samples of 0.3 ml were withdrawn and counted in a Packard scintillation spectrometer.
(ii) RSV-CEF cell system. CEF cells and Rous 29, 1979 on November 6, 2017 by guest http://jvi.asm.org/ Downloaded from to inhibit specifically EMC-infected mouse 3'1'6 cells (Table 1) . Certain compounds, including actinobolin, adrenochrome, blasticidin S, edeine Al, edeine complex, gougerotin, polydextran sulfate, and pyrocatechol violet have almost no effect on translation in normal 3T6 cells. Since these compounds block protein synthesis in cellfree systems, it seems likely that they cannot cross the plasma membrane. In contrast, some compounds, like cycloheximide, pactamycin, emetine, and tubulosine, appear to be more pow- The infected cells were synthesizing viral proteins when membrane leakiness occurred, and the antibiotics blocked the synthesis of all proteins, both cellular and viral (Fig. 1) . No inhibition of the synthesis of any particular protein of uninfected cells was detected. Of the three antibiotics tested, gougerotin showed the most clear discrimination between normal and infected cells, and consequently we chose this inhibitor for our subsequent studies.
Assuming that the inhibition of protein synthesis is caused by a change in permeability, it was important to determine at what time after infection this occurred. Figure 2 illustrates that, under our experimental conditions and using a low multiplicity of infection (1 to 2 PFU/cell), viral protein synthesis started at 4 h postinfection and continued for another 3 h. Inhibition by gougerotin became apparent at 5 h postinfection, at which time viral proteins were being synthesized, whereas total protein synthesis was decreasing. These results indicate that the synthesis of viral proteins occurs just prior to membrane leakiness, at least under conditions where a low multiplicity of infection is used.
In further experiments, infected cells were treated for 4 h with cycloheximide at a concentration high enough to block protein synthesis completely before addition of gougerotin. Subsequently the medium was removed and replaced by fresh medium. Under these conditions, membrane leakiness, as measured by the ability of gougerotin to inhibit translation, does not occur. Apparently, the permeability change is dependent on protein synthesis in the infected cell (Fig. 3) . In contrast to this result, treatment of infected cells with actinomycin D did not suppress the development of permeability to gougerotin, further strengthening the possibility that the synthesis of viral proteins is necessary for modification of the membrane. Infected cells were also treated with zinc ions, which are known to inhibit protease activity (13) , and this prevented inhibition by gougerotin (Fig. 3) . It is possible, therefore, that membrane leakiness requires the synthesis of mature viral proteins or, altematively, that zinc ions are able in some way to seal the leaks in the membrane.
The next step we pursued was to check membrane leakiness in other virus-cell systems. govirus-infected 3T6 cells, but their effect in control cells was much less potent (Fig. 4) .
SFV belongs to the Togaviridae family (18) . Hygromycin B and edeine complex inhibited protein synthesis in SFV-infected BHK cells, whereas their effect in control cells was much less potent (Fig. 5) . On the other hand, gougerotin and blasticidin S had little or no effect on control cells, but their inhibitory effect upon SFV-infected BHK cells was smaller than in the case of 3T6 cells infected by EMC virus (Fig. 1) or mengovirus (Fig. 4) , probably indicating that the altered permeability to drugs of togavirusinfected mammalian cells is less acute than in the case of picornavirus-infected cells. SV40 belongs to the Papovaviridae family and is unrelated to picornaviruses and togaviruses from the philogenetic point of view. Infection by SV40 of a susceptible cell can produce either lysis or transformation, depending on the host cell (19) . We analyzed SV40-promoted membrane leakage using the permissive CVl cell line that gives rise to productive infection and cell lysis. Because SV40 development takes place over a few days, membrane leakage was measured at 17 and 41 h postinfection. Edeine complex, gougerotin, and hygromycin B had little or no effect on control CV1 cells, whereas they blocked protein synthesis during the late phase of infection, when the synthesis of the viral coat protein VP1 was maximal (Fig. 6) . No effect was observed at the beginning of the late phase, indicating that the alteration of the membrane was brought about late in infection. These results are in agreement with recent observations in SV40-infected CV1 cells (15) .
RSV belongs to the Retroviridae family, and its development does not kill the host cell. Moreover, it does not induce shutoff of host cell protein synthesis (19) ; hence, it is not included in the membrane leakage model (3). However, it has been proposed that transformed cells could have a membrane with a few and regulable small pores (8) , and, in fact, it was found that transformed cells show a number of changes in their plasma membrane as compared with nornal cells (14) . Among these changes in permeability there is an increase in sugar and amino acid transport (12, 20) . Moreover, the membrane of transformed cells becomes leaky to some en- zymes (20) , and a number of drugs preferentially accumulate in cancerous tissues in naturally occurring malignancies (7) .
Therefore, a number of drugs, including actinobolin, adrenochrome, amicetin, anisomycin, aurintricarboxylic acid, blasticidin S, chartreusin, chlortetracycline, cycloheximide, deoxycycline, edeine complex, emetine, fusidic acid, gougerotin, GppCH2p, oxytetracycline, pactamycin, polydextran sulfate, puromycin, pyrocatechol violet, sparsomycin, and tubulosine, were tested for their inhibitory effect on protein synthesis in control and RSV-transformed CEF cells. A wide range of concentrations from 10'-to 10-M of the above-mentioned inhibitors and different incubation conditions were tested in these experiments. However, under these particular conditions no preferential effect with any drug was found on RSV-transformed 3T6 cells (conditions prop- erties. An inhibitor with the above characteristics could be a wide-spectrum antiviral agent, since membrane leakiness occurs in several virus-cell systems (4; and Fig. 1 and 4 
